Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available!
Here come GMP Grade Cytokines!Free Sample is available!
Immobilized Human IL-4, premium grade (Cat. No. IL4-H4218) at 5 μg/mL (100 μL/well)can bind Human IL-4 R alpha, Fc Tag (Cat. No. ILR-H5253) with a linear range of 1-20 ng/mL (QC tested).
The purity of Biotinylated Human IL-4 R alpha, Fc,Avitag (Cat. No. ILR-H82F4) is more than 90% and the molecular weight of this protein is around 120-147 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Stapokibart | CM-310 | Approved | Keymed Biosciences Co Ltd | 康悦达, Kangyueda | Mainland China | Dermatitis, Atopic | Chengdu Kangnuoxing Biopharma Inc | 2024-09-10 | Solid tumours; Rhinitis, Allergic, Seasonal; Pruritus; Nasal Polyps; Prurigo Nodularis; Conjunctivitis, Allergic; Rhinitis, Allergic; Prurigo; Asthma; Sinusitis; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Rademikibart | SIM0718; SIM-0718; CBP-201 | Phase 3 Clinical | Suzhou Connect Biopharmaceuticals Ltd | Nasal Polyps; Iron deficiency; Status Asthmaticus; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
QX-005N | QX-005N | Phase 3 Clinical | Qyuns Therapeutics Co Ltd | Nasal Polyps; Chronic Urticaria; Prurigo; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
siLR4A | siLR4A | Phase 3 Clinical | National Skin Centre, Singapore | Keloid; Wounds and Injuries | Details |
TQH2722 | TQC2722; TQC-2722; TQH 2722; TQH-2722; TQH2722; BSI-045A | Phase 3 Clinical | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group, Boaoxin Biotechnology(Nanjing) Co Ltd | Rhinitis, Allergic, Seasonal; Nasal Polyps; Rhinitis, Allergic; Sinusitis; Dermatitis, Atopic | Details |
GR-1802 | GR-1802; GR1802 | Phase 3 Clinical | Genrix (Shanghai) Biopharmaceutical Co Ltd | Rhinitis, Allergic, Seasonal; Nasal Polyps; Chronic Urticaria; Rhinitis, Allergic; Sinusitis; Asthma; Dermatitis, Atopic | Details |
SHR-1819 | SHR-1819 | Phase 3 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd | Chronic Urticaria; Nasal Polyps; Prurigo Nodularis; Sinusitis; Prurigo; Asthma; Dermatitis, Atopic | Details |
Manfidokimab | AK-120 (Akeso ) | Phase 3 Clinical | Zhongshan Akeso Biopharma Co Ltd | Asthma; Dermatitis, Atopic | Details |
Comekibart | MG-K-10; MG-K10; BC-005; MG-010 | Phase 3 Clinical | Shanghai Mabgeek Biotechnology Co Ltd | Rhinitis, Allergic, Seasonal; Nasal Polyps; Prurigo Nodularis; Eosinophilic Esophagitis; Asthma; Sinusitis; Dermatitis, Atopic | Details |
Recombinant anti-IL-4Rα humanized monoclonal antibody (Sansheng Guojian) | 611; 611 Q2W; 611 Q4W; 611-3SBio; SSGJ-611 | Phase 3 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Nasal Polyps; Polyps; Sinusitis; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
BA-2101 | BA-2101; BA2101; PR-103; PR103 | Phase 2 Clinical | Shandong Boan Biotechnology Co Ltd | Pruritus; Nasal Polyps; Chronic Urticaria; Prurigo; Urticaria; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Sorafenib Tosylate/Comekibart | MG-D-1609 | Phase 2 Clinical | Metagone Biotech Inc | Solid tumours | Details |
LQ-036 | LQ-036 | Phase 2 Clinical | Shanghai Novamab Biopharmaceuticals Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
Elarekibep | PRS-060/AZD1402; PRS-060; AZD-1402 | Phase 1 Clinical | University Of Melbourne, Pieris Pharmaceuticals | Asthma | Details |
NM26-2198 | NM-26-2198; NM26-2198 | Phase 1 Clinical | Numab Therapeutics Ag | Inflammation; Dermatitis, Atopic | Details |
Dupilumab biosimilar (Bio-Thera Solutions) | Phase 1 Clinical | Bio-Thera Solutions Ltd | Nasal Polyps; Prurigo Nodularis; Eosinophilic Esophagitis; Asthma; Sinusitis; Dermatitis, Atopic | Details | |
IBI-3002 | IBI3002; IBI-3002 | Phase 1 Clinical | Innovent Biologics(Suzhou) Co Ltd | Asthma | Details |
APG-808 | APG808; PR-001; PR001; APG-808 | Phase 1 Clinical | Paragon Therapeutics Inc, Apogee Therapeutics Inc | Pulmonary Disease, Chronic Obstructive | Details |
RC-1416 | RC14/16; RC-1416 | Phase 1 Clinical | Nanjing RegeneCore Biotech Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
HY-1770 | HY-1770; HT-17; HT17; YF02; HT25; GH02; HY1770 | Phase 1 Clinical | Suzhou Pharmavan Co Ltd | Plaque psoriasis; Dermatitis, Atopic | Details |
This web search service is supported by Google Inc.